Autologous bone marrow transplantation in acute leukemia

L. Mangoni, G. Degliantoni, A. Porcellini, A. M. Carella, E. P. Alessandrino, M. Aglietta, L. Resegott, G. Torlontano, P. Coleselli, R. Mozzana, E. Madon, V. Rizzoli

Research output: Contribution to journalArticlepeer-review


We evaluated the therapeutic efficacy of autologous bone marrow transplantation (ABMT) in 49 patients with acute leukemia, using ex-vivo-treated marrow with mafosfamide. This report summarizes data collected from 8 italian centers, involving 27 cases with acute lymphoid leukemia (ALL) and 22 cases with acute nonlymphoid leukemia (ANLL). The analysis of the results shows that the disease-free survival of ALL and ANLL are similar (45 and 52%, respectively) and no significant difference can be demonstrated between patients transplanted in CR1 or CR2, although there is a trend in favor of ABMT in CR1.

Original languageEnglish
Pages (from-to)190-193
Number of pages4
JournalActa Haematologica
Publication statusPublished - 1987


  • Acute leukemia
  • Autologous bone marrow transplantation
  • Mafosfamide
  • Purging

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Autologous bone marrow transplantation in acute leukemia'. Together they form a unique fingerprint.

Cite this